edaravone
General
Pronunciation:
e-dar-a-vone
![](.//images/locked-audio.png)
Trade Name(s)
- Radicava
- Radicava ORS
Ther. Class.
agents for amyotrophic lateral sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Edaravone." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. Medicine Central, im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110475/all/edaravone.
Vallerand AHA, Sanoski CAC, Quiring CC. Edaravone. Davis's Drug Guide. F.A. Davis Company; 2023. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110475/all/edaravone. Accessed September 8, 2024.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Edaravone. In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110475/all/edaravone
Vallerand AHA, Sanoski CAC, Quiring CC. Edaravone [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2024 September 08]. Available from: https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110475/all/edaravone.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - edaravone
ID - 110475
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://im.unboundmedicine.com/medicine/view/Davis-Drug-Guide/110475/all/edaravone
PB - F.A. Davis Company
ET - 18
DB - Medicine Central
DP - Unbound Medicine
ER -